. The difference in nasal obstruction between OSA patients and healthy individuals is not adequately documented. Our aim was to describe the sinonasal quality of life and nasal function in OSA patients and healthy controls using the sinonasal outcome test-20 (SNOT-20), nasal obstruction visual analog scale (NO-VAS), and peak nasal inspiratory flow (PNIF). . Ninety-three OSA patients and 92 controls were included in a case-control study from 2010 to 2015. . Mean SNOT-20 score in the OSA group was 1.69 (SD 0.84) compared to 0.55 (SD 0.69) in controls ( < 0.001, 95% CI [0.9, 1.4]). The mean NO-VAS score was 41.3 (SD 12.8) and 14.7 (SD 14.4) in the OSA group and controls, respectively, ( < 0.001, 95% CI [22.7, 30.6]). PNIF measured 105 litres/minute in the OSA group and 117 litres/minute in controls ( < 0.01, 95% CI [-21.8, -3.71]). There was a positive correlation between subjective nasal obstruction and change in PNIF after decongestion in the control group alone. . OSA patients have a reduced sinonasal QoL and lower peak nasal inspiratory flow compared to controls. Treatment of nasal obstruction in OSA patients should be made a priority along with treatment of the ailment itself.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436061PMC
http://dx.doi.org/10.1155/2017/1935284DOI Listing

Publication Analysis

Top Keywords

osa patients
20
nasal obstruction
16
osa group
12
healthy controls
8
osa
8
obstruction osa
8
patients healthy
8
peak nasal
8
nasal inspiratory
8
inspiratory flow
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!